CNCR vs. IPOS ETF Comparison
Comparison of Loncar Cancer Immunotherapy ETF (CNCR) to Renaissance Capital Greenwich Fund (IPOS)
CNCR
Loncar Cancer Immunotherapy ETF
CNCR Description
ETF Series Solutions - Loncar Cancer Immunotherapy ETF is an exchange traded fund launched by ETF Series Solutions. The fund is co-managed by Exchange Traded Concepts, LLC and Vident Investment Advisory, LLC. It invests in public equity markets of the United States. The fund invests in stocks of companies operating in the pharmaceutical or biotechnology sectors, including those companies identified as having a high strategic focus on the development of drugs that harness the body's own immune system to fight cancer. It invests in stocks of companies across all market capitalizations. The fund seeks to replicate the performance of the Loncar Cancer Immunotherapy Index, by investing in stocks of companies as per their weightings in the index. ETF Series Solutions - Loncar Cancer Immunotherapy ETF is domiciled in the United States.
Grade (RS Rating)
Last Trade
$14.36
Average Daily Volume
45,522
71
IPOS
Renaissance Capital Greenwich Fund
IPOS Description
The investment seeks replicate as closely as possible, before fees and expenses, the price and yield performance of the Renaissance International IPO Index. The index is a portfolio of companies that have recently completed an initial public offering ("IPOs") that is listed on a non-U.S. exchange. IPOs are an unseasoned category of equities under-represented in core equity indices. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index, the Renaissance International IPO Index. It is non-diversified.Grade (RS Rating)
Last Trade
$13.52
Average Daily Volume
1,807
1
Performance
| Period | CNCR | IPOS |
|---|---|---|
| 30 Days | -9.74% | -1.62% |
| 60 Days | -12.01% | 2.43% |
| 90 Days | 7.81% | 7.38% |
| 12 Months | 11.32% | -16.64% |
0 Overlapping Holdings
| Symbol | Grade | Weight in CNCR | Weight in IPOS | Overlap |
|---|
CNCR Overweight 71 Positions Relative to IPOS
| Symbol | Grade | Weight | |
|---|---|---|---|
| GERN | A | 2.62% | |
| ACRV | A | 2.52% | |
| ELVN | B | 2.3% | |
| JANX | A | 1.83% | |
| NUVB | B | 1.75% | |
| TSVT | F | 1.68% | |
| PRLD | D | 1.68% | |
| RVMD | A | 1.48% | |
| NRIX | A | 1.47% | |
| ITOS | D | 1.46% | |
| LYEL | B | 1.45% | |
| GLUE | B | 1.44% | |
| ACET | F | 1.43% | |
| FHTX | D | 1.41% | |
| HCM | A | 1.4% | |
| MGNX | B | 1.4% | |
| MRK | B | 1.39% | |
| STRO | F | 1.37% | |
| AURA | F | 1.35% | |
| RAPT | F | 1.35% | |
| EXEL | A | 1.34% | |
| MOR | A | 1.34% | |
| SDGR | F | 1.32% | |
| INBX | C | 1.32% | |
| YMAB | C | 1.32% | |
| GMAB | D | 1.3% | |
| VOR | F | 1.3% | |
| DAWN | B | 1.3% | |
| CGEM | B | 1.3% | |
| PGEN | F | 1.3% | |
| BPMC | A | 1.29% | |
| IPHA | F | 1.28% | |
| ERAS | F | 1.28% | |
| BCYC | B | 1.27% | |
| SNDX | D | 1.27% | |
| BNTX | F | 1.26% | |
| REGN | C | 1.25% | |
| DCPH | D | 1.25% | |
| ZNTL | F | 1.25% | |
| IGMS | F | 1.23% | |
| IMCR | D | 1.23% | |
| BMY | F | 1.23% | |
| MRUS | D | 1.23% | |
| IDYA | D | 1.23% | |
| XNCR | F | 1.22% | |
| DNA | F | 1.19% | |
| RCUS | F | 1.18% | |
| KYMR | D | 1.16% | |
| KPTI | D | 1.15% | |
| KURA | D | 1.15% | |
| IMTX | D | 1.15% | |
| SWTX | D | 1.14% | |
| AUTL | D | 1.14% | |
| TYRA | D | 1.11% | |
| RLAY | F | 1.11% | |
| IOVA | D | 1.11% | |
| ACLX | D | 1.09% | |
| REPL | F | 1.07% | |
| ALLO | F | 1.05% | |
| FATE | D | 1.04% | |
| LEGN | F | 1.04% | |
| NUVL | D | 1.03% | |
| ARVN | D | 1.03% | |
| SMMT | D | 1.02% | |
| MRSN | D | 1.01% | |
| CRBU | F | 1.01% | |
| BMEA | F | 0.99% | |
| RXRX | F | 0.96% | |
| IMRX | F | 0.88% | |
| RPTX | F | 0.88% | |
| GNLX | F | 0.81% |
CNCR Underweight 1 Positions Relative to IPOS
| Symbol | Grade | Weight | |
|---|---|---|---|
| LSPD | F | -1.71% |
CNCR: Top Represented Industries & Keywords
IPOS: Top Represented Industries & Keywords
Compare ETFs
